A team led by Mass General Brigham researchers demonstrated that inebilizumab reduced the risk of symptoms by 87% in patients with the rare affliction known as immunoglobulin G4–related disease (IgG4- ...
Physicians are learning how to better support the needs of people with rheumatoid arthritis (RA) from online search trends, according to a new study from researchers at Hospital for Special Surgery ...